Monsanto Co. (MON) Given New $128.00 Price Target at Monness Crespi & Hardt
A number of other equities research analysts have also recently weighed in on MON. S&P Equity Research restated a positive rating on shares of Monsanto in a research note on Thursday, September 15th. JPMorgan Chase & Co. restated a hold rating on shares of Monsanto in a research note on Thursday, June 30th. Zacks Investment Research cut Monsanto from a hold rating to a sell rating in a research note on Friday, July 1st. Vetr upgraded Monsanto from a buy rating to a strong-buy rating and set a $117.09 price objective for the company in a research note on Wednesday, August 3rd. Finally, Jefferies Group restated a buy rating on shares of Monsanto in a research note on Wednesday, June 29th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of Buy and an average target price of $114.21.
Monsanto (NYSE:MON) traded up 0.05% on Monday, hitting $102.52. The stock had a trading volume of 1,047,253 shares. The stock has a market cap of $44.86 billion, a P/E ratio of 45.12 and a beta of 1.19. The company’s 50 day moving average is $105.05 and its 200-day moving average is $101.24. Monsanto has a 12 month low of $83.73 and a 12 month high of $114.26.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 2.11%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s payout ratio is 89.26%.
In other Monsanto news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now owns 21,583 shares in the company, valued at approximately $2,196,501.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. Company insiders own 0.88% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the company. Meiji Yasuda Asset Management Co Ltd. raised its stake in shares of Monsanto by 4.2% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 30,933 shares of the company’s stock valued at $2,714,000 after buying an additional 1,260 shares during the period. Carnick & Kubik LLC purchased a new stake in shares of Monsanto during the first quarter valued at approximately $130,000. Smith Moore & CO. raised its stake in shares of Monsanto by 29.9% in the first quarter. Smith Moore & CO. now owns 11,485 shares of the company’s stock valued at $1,008,000 after buying an additional 2,641 shares during the period. Ropes Wealth Advisors LLC raised its stake in shares of Monsanto by 5.5% in the first quarter. Ropes Wealth Advisors LLC now owns 2,798 shares of the company’s stock valued at $245,000 after buying an additional 147 shares during the period. Finally, M&T Bank Corp raised its stake in shares of Monsanto by 16.4% in the first quarter. M&T Bank Corp now owns 77,720 shares of the company’s stock valued at $6,820,000 after buying an additional 10,927 shares during the period. Institutional investors own 79.02% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.